Cite
Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index.
MLA
Lech-Maranda, Ewa, et al. “Plasma TNF-Alpha and IL-10 Level-Based Prognostic Model Predicts Outcome of Patients with Diffuse Large B-Cell Lymphoma in Different Risk Groups Defined by the International Prognostic Index.” Archivum Immunologiae et Therapiae Experimentalis, vol. 58, no. 2, Apr. 2010, pp. 131–41. EBSCOhost, https://doi.org/10.1007/s00005-010-0066-1.
APA
Lech-Maranda, E., Bienvenu, J., Broussais-Guillaumot, F., Warzocha, K., Michallet, A.-S., Robak, T., Coiffier, B., & Salles, G. (2010). Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index. Archivum Immunologiae et Therapiae Experimentalis, 58(2), 131–141. https://doi.org/10.1007/s00005-010-0066-1
Chicago
Lech-Maranda, Ewa, Jacques Bienvenu, Florence Broussais-Guillaumot, Krzysztof Warzocha, Anne-Sophie Michallet, Tadeusz Robak, Bertrand Coiffier, and Gilles Salles. 2010. “Plasma TNF-Alpha and IL-10 Level-Based Prognostic Model Predicts Outcome of Patients with Diffuse Large B-Cell Lymphoma in Different Risk Groups Defined by the International Prognostic Index.” Archivum Immunologiae et Therapiae Experimentalis 58 (2): 131–41. doi:10.1007/s00005-010-0066-1.